Accord's portfolio spans across critical therapeutic fields such as oncology, cardiology, neurology, psychiatry, diabetes, pain management and gastroenterology.

Accord has one of the most dynamic product pipelines in the pharmaceutical industry. Our medicines span across multiple therapeutic classes, and we are committed to building this …

Il nostro Codice di condotta per i partner commerciali illustra le nostre aspettative nei confronti delle organizzazioni e degli individui che lavorano con Accord e le sue controllate e contiene …

If you have concerns related to Integrity at Accord there are a number of ways you can raise a concern. You can speak to your Accord Business Partner or speak to our confidential hotline.

Accord Healthcare MENA FZCO registers, markets, and sells a wide range of well-established, essential and innovative medicines for human use. Capitalising on its parent and affiliate …

At Accord we are driven to increase patient access to essential cancer therapies across Europe. By the means of our extensive portfolio comprising over 30 chemotherapeutic agents, Accord …

Accord are one of the leading generic pharmaceutical companies in the UK. Our extensive range of generic medicines act as the backbone of local healthcare, providing accessible, effective …

Accord est constamment à la recherche de moyens innovants pour mieux soutenir les patients et les professionnels de santé. Notre agilité et notre flexibilité nous distinguent des autres …

A Accord desenvolve, produz e distribui uma vasta gama de medicamentos essenciais para farmácias hospitalares e farmácias comunitárias em toda a Europa e no resto do mundo.

Accord is one of the fastest growing pharmaceutical and biosimilars companies in Europe with one of the largest market footprints of any European generic company, selling medicines in …